Prof. Jean-Michel Dogné appointed member of the WHO's Global Advisory Committee on Vaccine Safety

Prof. Jean-Michel Dogné is director of the Pharmacy Department of the UNamur and member of the NARILIS institute. Since many years, he has been offering expert advisory services to the Federal Agency for Medicines and Health Products (FAMHP) and the European Medicines Agency (EMA). Building on his strong expertise in pharmacovigilance, Jean-Michel Dogné has now just been appointed as a member of the World Health Organization’s Global Advisory Committee on Vaccine Safety (GACVS).

By integrating the FAMPH and the EMA in 2006, Jean-Michel Dogné gained experience in the identification and management of potential risks associated with vaccines. He provided for example recommendations in the framework of Mosquirix (vaccine against malaria) Cervarix (vaccine against human papillomavirus linked to cancers of the cervix or anus) and Ervebo (vaccine against Ebola virus).

Jean-Michel Dogné will now serve for 3 years as a member of the WHO’s GACVS, alongside with 14 acknowledged experts from around the world and specialized in different fields related to vaccination, such as epidemiology, pharmacology, toxicology, infectious diseases, public health, etc… Thanks to his recognized expertise in vaccine pharmacovigilance, he will participate to the formulation of scientific advice to the WHO on general vaccine safety issues of potential global importance.
No doubt that this new international responsibility will also benefit future students entering the master in pharmaceutical sciences launched in Namur in September 2020!